XSOLIS

Nashville, United States Founded: 2013 • Age: 13 yrs
AI-based platform for physicians and payers to analyze denial management

About XSOLIS

XSOLIS is a Healthcare company based in Nashville (United States) founded in 2013. AI-based platform for physicians and payers to analyze denial management. It operates in the Healthcare and Technology sectors. XSOLIS has raised $75 million across 2 funding rounds from investors including Brighton Park Capital. The company has 166 employees. XSOLIS has completed 1 acquisition, including MEDarchon. Its chief executive, as recorded, is Joan Butters. XSOLIS offers products and services including Dragonfly Platform, Physician Advisor Services, and Denial Services. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its competitors include Infinx, AKASA and Plusgrade; 2 of its 3 listed competitors have raised funding.

Company details

XSOLIS was founded in 2013 and is headquartered in Nashville, United States. An AI-based platform is offered to physicians and payers in the healthcare sector for managing claim denials. Operations focus on analyzing potential denials during claims processing to support efficient resolution. Services include tools for identifying and addressing denial risks across payer interactions.

  • Headquarters Nashville, United States
  • Employees 166
  • Sectors
    Healthcare
    Technology
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website xsolis.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $75M (USD)

    in 2 rounds

  • Latest Funding Round
    $75M (USD), Series C

    Jun 2021

  • Investors
  • Employee Count
    166
  • Investments & Acquisitions

Products & Services of XSOLIS

XSOLIS offers a comprehensive portfolio of products and services, including Dragonfly Platform, Physician Advisor Services, and Denial Services.

Dragonfly Platform
AI Software

Provides real-time analytics for patient care and utilization review.

Physician Advisor Services
Consulting Services

Supplements staff with AI-driven clinical advice and coverage.

Denial Services
Management Services

Manages appeals and documentation for revenue optimization.

Funding Insights of XSOLIS

XSOLIS has successfully raised a total of $75M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $75M
  • Total Rounds 2
  • Last Round Series C β€” $75M
  • First Round $4M

    (Sep 2018)

  • Investors Count 1

All 2 funding rounds of XSOLIS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2021$75MSeries C–Brighton Park Capital
–
Sep 2018$4MDebt – Conventional––
–
Valuation history

1 investors in total: 1 institutional.

Investors in XSOLIS

XSOLIS has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Brighton Park Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Brighton Park Capital is focused on growth equity investments.
bpc.comGreenwich, United States
Premium access

Investor details for XSOLIS

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of XSOLIS

97 people are tracked at XSOLIS (48 in leadership, 49 in team); the tracked headcount is 166.

NameRoleGroup
Joan Butters
CEOLeadership
Zach Evans
Chief Technology OfficerLeadership
Brent Teveit
Chief Data Science OfficerLeadership
Heather Bassett
Chief Medical OfficerLeadership
Hope Giannetto
Enterprise Sales Director, ProviderLeadership
Bethany Barnes
Director, Client Operations ManagementLeadership
Doug Knolles
Regional Sales DirectorLeadership
Emily Blessing
Director Of Project Management, Client DeliveryLeadership
Shelia Foster
Director Of Program ManagementLeadership
Mallika Edwards
Chief Product OfficerLeadership
Jamie Anderson
Enterprise Sales Director, ProviderLeadership
Tim Kostner
Chief Revenue OfficerLeadership
Makeyta L.
Value Realization Partner IIILeadership
Chris Bayham
Chief Operations OfficerLeadership
Rachel Vincion
Chief Finance OfficerLeadership
Heather Clark
Sr. Director Of Revenue OperationsLeadership
Ian Vickers
Regional Sales DirectorLeadership
Manisha Sharma
Sr. Director AI Product ManagementLeadership
Carlos Torres
Director Of Software EngineeringLeadership
Courtney C.
Director Of Engineering OperationsLeadership

77 more people are available in the full profile.

Premium access

Complete people profiles for XSOLIS

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by XSOLIS

XSOLIS has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MEDarchon.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Mobile-based care coordination system for hospitals and clinics along with analytics to predict patients at risk.
medarchon.comNashville, United States2012Nov 2019β€’β€’β€’β€’
Premium access

Complete acquisition details for XSOLIS

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of XSOLIS

4 dated milestones of XSOLIS across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded XSOLIS is founded.
  2. Funding First funding round of $4.0M.
  3. Acquisition Acquires MEDarchon.
  4. Funding Latest funding round, Series C, of $75.0M.

Competitors of XSOLIS

XSOLIS has 3 listed competitors in our database, 2 of them funded. They include Infinx, AKASA and Plusgrade.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
infinx.com2010San Francisco, United States6,350
Revenue cycle management platform for healthcare is provided.
akasa.com2018San Francisco, United States$80M46
Revenue cycle automation platforms are provided for healthcare reimbursement.
plusgrade.com2009New York, United States$150.67M
SaaS revenue management solutions are offered to airlines for optimization.
Premium access

Detailed competitors of XSOLIS

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of XSOLIS

The website of XSOLIS (xsolis.com) receives about 8.9K visits a month.

  • Monthly visits
    8.9K

    ▼ 5.9% vs previous month

Similar websites

Websites whose visitors overlap most with XSOLIS. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ehidc.org
ehidc.org
100%
#5,073,473–
auxein.com
84%
13.4K#1,870,288View details
keragon.com
84%
46.1K#683,508View details
foreseemed.com
84%
39K#873,558View details
openloophealth.com
84%
108.8K#269,312View details

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as XSOLIS (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Xsolis

Premium access

Complete news archive for XSOLIS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about XSOLIS

XSOLIS was founded in 2013 and raised its 1st funding round 5 years after it was founded.

XSOLIS is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.

Joan Butters is the CEO of XSOLIS, as recorded in our data.

XSOLIS is a funded company, having raised a total of $75M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $4M, raised on Sep 2018.

XSOLIS has 166 employees.

XSOLIS was founded in 2013 and is headquartered in Nashville, United States. An AI-based platform is offered to physicians and payers in the healthcare sector for managing claim denials. Operations focus on analyzing potential denials during claims processing to support efficient resolution. Services include tools for identifying and addressing denial risks across payer interactions.

XSOLIS's top competitors include AKASA, Infinx and Plusgrade.

XSOLIS offers Dragonfly Platform, Physician Advisor Services, and Denial Services.

XSOLIS has made 1 acquisition, including MEDarchon.

XSOLIS has 1 investor. Key investors include Brighton Park Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available